Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial. (2022)

First Author: Bailón L
Attributed to:  Definition and induction of broadly protective responses against HIV-1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-02060-2

PubMed Identifier: 36302893

Publication URI: http://europepmc.org/abstract/MED/36302893

Type: Journal Article/Review

Volume: 28

Parent Publication: Nature medicine

Issue: 12

ISSN: 1078-8956